IRCT20220702055337N1
Recruiting
Phase 3
The effect of amikacin in the prevention of ventilator-induced pneumonia in patients admitted IC
Overview
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 126
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Age 18 and above
- •Absence of lung disease and lung mass
- •No use of chemotherapy drugs
- •Absence of intestinal nutrition
- •No receiving of Antibiotics before the onset of VAP
- •Absence of kidney disease and chronic kidney failure with basic glomerular filtration less than 30 ml in minutes
- •No removing the patient's tracheal tube within the next 48 hours after insertion
- •Lack of sensitivity to amikacin
- •Absence of Myasthenia gravis
- •Not pregnant or Lactating
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative BacteriaPneumonia, Ventilator-AssociatedNCT02574130Thammasat University60
Active, not recruiting
Phase 1
ebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO)gram-negative bacillus pneumonia acquired during mechanical ventilation in patients receiving Extracorporeal Membrane veno-arterial oxygenationMedDRA version: 20.1Level: LLTClassification code: 10035701Term: Pneumonia gram-negative bacterial NOS Class: 10021881MedDRA version: 20.0Level: SOCClassification code: 10021881Term: Infections and infestations Class: 1Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]CTIS2023-509722-22-00Assistance Publique Hopitaux De Paris26
Unknown
Phase 2
Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical VentilationVentilator Associated PneumoniaNCT00861315Association Pour La Promotion A Tours De La Reanimation Medicale24
Recruiting
Not Applicable
Effect of inhaled Amikacin and Colistin in prevention of pneumoniaIRCT20201015049030N3Tehran University of Medical Sciences126
Not yet recruiting
Phase 4
Which is better in between Nebulized Polymyxin E and Nebulized Amikacin for the prevention ofventilator-associated pneumoniaHealth Condition 1: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classifiedCTRI/2024/07/070824ttarpradesh University of medical sciences